EUVIMEDEUVIMED entdecken
Crossref

Characteristics of Transfection Reagents that Achieve High Production of Recombinant Adeno-Associated Virus Vectors

Kyoko Masumi-Koizumi, Emi Ito-Kudo, Yuzhe Yuan, Noriko Hashiba, Keisuke Yusa, Kazuhisa Uchida

Human Gene Therapy · 2026

DOI: 10.1177/10430342251386006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Gene Therapy, 2026. Verfasst von Kyoko Masumi-Koizumi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Science, Technology and Innovation, Kobe University, Kobe, Japan. Hauptthemen laut MEDLINE: Dependovirus, Genetic Vectors, Transfection. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recombinant adeno-associated virus (rAAV) vectors are among the most effective for gene therapy. A significant advancement in rAAV vector production is developing the triple-plasmid transfection method, which remains the most widely used technique. In this study, we used Expi293F TM (Expi293F) and Viral Production Cells 2.0 (VPC2.0 cells) to evaluate various transfection reagents, comparing transgene protein expression levels and intracellular plasmid copy numbers to optimize rAAV production. Our findings indicated that the effectiveness of transfection reagents in promoting higher rAAV production was cell-dependent and that rAAV productivity correlated more with plasmid levels in the cell nucleus than with transgene protein expression levels. Confocal laser microscopy revealed that in cells transfected with the high-yield transfection reagent, a large amount of free plasmid DNA entered the nucleus, whereas the transfection reagents themselves did not. These results provide new insights into the intracellular mechanisms underlying efficient rAAV vector production. Furthermore, identifying transfection reagents that facilitate nuclear plasmid delivery will aid in the selection of optimal reagents for high-yield AAV production.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DependovirusGenetic VectorsTransfectionHumansPlasmidsCell NucleusTransgenesCell LineHEK293 CellsGenetic Therapy

Stichwörter der Autor:innen

adeno-associated virusgenome titerintracellular plasmid copiesnuclear localizationtransfection reagent

Autor:innen und Institutionen

  • Graduate School of Science, Technology and Innovation, Kobe University, Kobe, Japan.

Förderung

  • Japan Agency for Medical Research and Development

Zitieren

APA

Masumi-Koizumi, K., Ito-Kudo, E., Yuan, Y., Hashiba, N., Yusa, K., & Uchida, K. (2026). Characteristics of Transfection Reagents that Achieve High Production of Recombinant Adeno-Associated Virus Vectors. Human Gene Therapy. https://doi.org/10.1177/10430342251386006

Vancouver

Masumi-Koizumi K, Ito-Kudo E, Yuan Y, Hashiba N, Yusa K, Uchida K. Characteristics of Transfection Reagents that Achieve High Production of Recombinant Adeno-Associated Virus Vectors. Human Gene Therapy. 2026. doi:10.1177/10430342251386006

BibTeX
@article{MasumiKoizumi2026,
  author = {Masumi-Koizumi, Kyoko and Ito-Kudo, Emi and Yuan, Yuzhe and Hashiba, Noriko and Yusa, Keisuke and Uchida, Kazuhisa},
  title = {Characteristics of Transfection Reagents that Achieve High Production of Recombinant Adeno-Associated Virus Vectors},
  journal = {Human Gene Therapy},
  year = {2026},
  doi = {10.1177/10430342251386006}
}
Kostenlos starten →